Afya (NASDAQ:AFYA) Stock Price Down 4.9% – What’s Next?

Afya Limited (NASDAQ:AFYA)’s stock price was down 4.9% on Friday. The company traded as low as $13.15 and last traded at $13.06. Approximately 53,162 shares changed hands during mid-day trading, a decline of 59% from the average daily volume of 130,384 shares. The stock had previously closed at $13.73.

Afya News Roundup

Here are the key news stories impacting Afya this week:

• Positive Sentiment: Merger creates a substantially larger education platform. Afya and Yduqs signed a binding agreement to combine their Brazilian higher-education operations, creating a group with approximately 1.6 million students and R$9.4 billion in revenue. Afya shareholders are expected to own about 69.3% of the combined company. Afya and Yduqs merger agreement
• Positive Sentiment: Potential for synergies and stronger cash generation. Management commentary and analyst scenarios point to accelerated cash-flow generation, further consolidation opportunities and potentially significant operating synergies. The agreement also reportedly contemplates approximately R$750 million in dividends. JPMorgan merger scenarios
• Neutral Sentiment: Analyst valuation remains above the recent trading level. Afya has a consensus target price of $17.75, suggesting analysts see potential upside, although the target may not yet reflect the final merger structure or transaction risks. Afya consensus target price
• Negative Sentiment: Short interest increased sharply. Reported short interest as of September 15 reached 1.41 million shares, up 163.2% from August 31, with 5.2 days to cover. This indicates that some traders are positioning for further weakness, although the data conflicts with a separate report showing zero short interest. Afya short-interest data
• Negative Sentiment: Investors face transaction uncertainty. Reports indicate the deal could eventually remove AFYA from Nasdaq while maintaining Yduqs’ B3 listing. Integration costs, regulatory approvals, the final share-exchange terms and possible dilution may be weighing on the stock. Zacks also placed AFYA on its Rank #5 “Strong Sell” list. Potential Nasdaq delisting report

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Bank of America reissued a “neutral” rating on shares of Afya in a research note on Thursday, June 11th. JPMorgan Chase & Co. decreased their target price on shares of Afya from $21.50 to $21.00 and set a “neutral” rating for the company in a research note on Monday, June 22nd. Wall Street Zen raised Afya from a “hold” rating to a “buy” rating in a research report on Saturday, September 5th. Bradesco Corretora upgraded Afya to an “outperform” rating and set a $17.00 price target on the stock in a research note on Thursday. Finally, Weiss Ratings downgraded Afya from a “hold (c)” rating to a “hold (c-)” rating in a research note on Friday, July 31st. One research analyst has rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $17.75.

Afya Stock Down 5.3%

The company has a 50 day moving average price of $14.01 and a two-hundred day moving average price of $14.34. The company has a debt-to-equity ratio of 0.39, a current ratio of 2.20 and a quick ratio of 2.20. The stock has a market cap of $1.22 billion, a PE ratio of 7.94, a PEG ratio of 1.51 and a beta of 0.35.

Afya (NASDAQ:AFYA) last issued its earnings results on Friday, August 14th. The company reported $0.43 earnings per share for the quarter, topping analysts’ consensus estimates of $0.40 by $0.03. Afya had a return on equity of 17.58% and a net margin of 20.55%.The business had revenue of $187.80 million during the quarter, compared to analyst estimates of $189.62 million. Analysts expect that Afya Limited will post 1.86 EPS for the current year.

Insider Buying and Selling at Afya

In other news, VP Lélio de Souza, Jr. sold 36,204 shares of the business’s stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $15.00, for a total transaction of $543,060.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.80% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Afya

A number of institutional investors have recently bought and sold shares of the stock. Swedbank AB increased its position in Afya by 170.3% in the fourth quarter. Swedbank AB now owns 189,200 shares of the company’s stock worth $2,916,000 after buying an additional 119,200 shares in the last quarter. Engineers Gate Manager LP purchased a new position in shares of Afya during the 2nd quarter valued at about $325,000. Public Employees Retirement System of Ohio bought a new position in shares of Afya during the 2nd quarter valued at approximately $67,000. Finally, Banco BTG Pactual S.A. bought a new position in shares of Afya during the 4th quarter valued at approximately $462,000. 88.02% of the stock is owned by institutional investors.

About Afya

Afya Limited is a Brazilian medical education and technology company that operates an integrated platform for physicians and medical students. The company provides education and professional development throughout the medical career cycle, from undergraduate training and residency preparation to continuing medical education and specialization programs.

Afya’s offerings include medical schools, preparatory courses, postgraduate and continuing education programs, digital learning tools, and clinical practice technologies.